BRÈVE publiée le 24/03/2025 à 14:41, il y a 10 mois 12 jours Eurofins Scientific SE Announces Changes in Share Capital and Voting Rights Share Capital Voting Rights Shareholder Transparency Eurofins Scientific SE Equity Management
BRÈVE publiée le 24/03/2025 à 14:41, il y a 10 mois 12 jours Eurofins Scientific SE annonce des modifications de son capital social et de ses droits de vote Capital Social Droit De Vote Eurofins Scientific SE Transparence Des Actionnaires Gestion Des Actions
COMMUNIQUÉ DE PRESSE publié le 24/03/2025 à 14:36, il y a 10 mois 12 jours Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Disclosure of voting rights and capital by Eurofins Scientific SE according to transparency requirements for issuers of securities Securities Voting Rights Capital Transparency Requirements Eurofins Scientific SE
BRÈVE publiée le 19/03/2025 à 20:34, il y a 10 mois 16 jours Eurofins Scientific SE Launches Fifth Share Buy-Back Programme Share Buy-back Investment Strategy Financial Services Long-term Incentive Eurofins
BRÈVE publiée le 19/03/2025 à 20:34, il y a 10 mois 16 jours Eurofins Scientific SE lance son cinquième programme de rachat d'actions Rachat D'actions Stratégie D'investissement Services Financiers Incitation À Long Terme Eurofins
COMMUNIQUÉ DE PRESSE publié le 19/03/2025 à 20:29, il y a 10 mois 16 jours Acquisition or disposal of the issuer's own shares / Description of the buyback program Eurofins Scientific SE announces its fifth buy-back programme of own shares, aiming to repurchase up to 4.5% of share capital. Programme starts on 20 March 2025 Share Capital Investor Relations Own Shares Buy-back Programme Eurofins
BRÈVE publiée le 26/02/2025 à 07:52, il y a 11 mois 7 jours Eurofins Publishes 2024 Annual Report Financial Statements Annual Report Luxembourg Stock Exchange Eurofins Bio-analysis
BRÈVE publiée le 26/02/2025 à 07:52, il y a 11 mois 7 jours Eurofins publie son rapport annuel 2024 États Financiers Rapport Annuel Bourse De Luxembourg Eurofins Bio-analyse
COMMUNIQUÉ DE PRESSE publié le 26/02/2025 à 07:47, il y a 11 mois 7 jours Annual financial and audit reports / Terms of availability of the annual financial report Eurofins releases its 2024 Annual Report, including Management, Remuneration, and Corporate Governance Reports. Available on Eurofins website. Contact Investor Relations for more info Financial Statements Investor Relations Corporate Governance Eurofins 2024 Annual Report
BRÈVE publiée le 19/02/2025 à 17:52, il y a 11 mois 13 jours EUROFINS SCIENTIFIC SE Updates Voting Rights Disclosure Shareholder Information Financial Disclosure Capital Structure Eurofins Scientific SE Voting Rights Update
Publié le 05/02/2026 à 11:30, il y a 3 heures 59 minutes Déclaration nombre d'actions et droits de vote - 05.02.2026
Publié le 05/02/2026 à 11:30, il y a 3 heures 59 minutes Disclosure of shares outstanding and voting rights - 05.02.2026
Publié le 04/02/2026 à 18:04, il y a 21 heures 25 minutes Capital et droits de vote au 31 janvier 2026
Publié le 04/02/2026 à 18:04, il y a 21 heures 25 minutes Total number of voting rights and shares making up the share capital at January 31, 2026
Publié le 04/02/2026 à 17:45, il y a 21 heures 44 minutes Information concerning the total number of voting rights and shares 2026 01 31
Publié le 05/02/2026 à 15:10, il y a 19 minutes Electric Metals (USA) Limited Announces Change of Auditor
Publié le 05/02/2026 à 14:50, il y a 39 minutes High Tide Resources Announces Non-Brokered Private Placements
Publié le 05/02/2026 à 14:30, il y a 59 minutes Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Publié le 05/02/2026 à 14:30, il y a 59 minutes Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
Publié le 05/02/2026 à 14:00, il y a 1 heure 29 minutes Organto Foods Inc. Expects Strong 2026 Growth Driven by Retail Wins and Expanded Supply Partnerships
Publié le 05/02/2026 à 15:15, il y a 13 minutes FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
Publié le 05/02/2026 à 15:12, il y a 17 minutes Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
